Literature DB >> 19553557

Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.

Ho Seong Seo1, Moon H Nahm.   

Abstract

To identify the Toll-like receptor 2 ligand critically involved in infections with gram-positive bacteria, lipoprotein lipase (LPL) or hydrogen peroxide (H(2)O(2)) is often used to selectively inactivate lipoproteins, and hydrofluoric acid (HF) or platelet-activating factor-acetylhydrolase (PAF-AH) is used to selectively inactivate lipoteichoic acid (LTA). However, the specificities of these chemical reactions are unknown. We investigated the reaction specificities by using two synthetic lipoproteins (Pam(3)CSK(4) and FSL-1) and LTAs from pneumococci and staphylococci. Changes in the structures of the two synthetic proteins and the LTAs were monitored by mass spectrometry, and biological activity changes were evaluated by measuring tumor necrosis factor alpha production by mouse macrophage cells (RAW 264.7) following stimulation. PAF-AH inactivated LTA without reducing the biological activities of Pam(3)CSK(4) and FSL-1. Mass spectroscopy confirmed that PAF-AH monodeacylated pneumococcal LTA but did not alter the structure of either Pam(3)CSK(4) or FSL-1. As expected, HF treatment reduced the biological activity of LTA by more than 80% and degraded LTA. HF treatment not only deacylated Pam(3)CSK(4) and FSL-1 but also reduced the activities of the lipoproteins by more than 60%. Treatment with LPL decreased the biological activities by more than 80%. LPL also removed an acyl chain from the LTA and reduced its activity. Our results indicate that treatment with 1% H(2)O(2) for 6 h at 37 degrees C inactivates Pam(3)CSK(4), FSL-1, and LTA by more than 80%. Although HF, LPL, and H(2)O(2) treatments degrade and inactivate both lipopeptides and LTA, PAF-AH selectively inactivated LTA with no effect on the biological and structural properties of the two lipopeptides. Also, the ability of PAF-AH to reduce the inflammatory activities of cell wall extracts from gram-positive bacteria suggests LTA to be essential in inflammatory responses to gram-positive bacteria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553557      PMCID: PMC2725534          DOI: 10.1128/CVI.00115-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  63 in total

1.  Innate immunity to pathogens: diversity in receptors for microbial recognition.

Authors:  Shizuo Akira
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

2.  Lipoprotein lipase controls fatty acid entry into adipose tissue, but fat mass is preserved by endogenous synthesis in mice deficient in adipose tissue lipoprotein lipase.

Authors:  P H Weinstock; S Levak-Frank; L C Hudgins; H Radner; J M Friedman; R Zechner; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Microbiologic findings and correlations with serum tumor necrosis factor-alpha in patients with severe sepsis and septic shock.

Authors:  J Cohen; E Abraham
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

5.  Surface-expressed TLR6 participates in the recognition of diacylated lipopeptide and peptidoglycan in human cells.

Authors:  Yoshiya Nakao; Kenji Funami; Satomi Kikkawa; Mitsue Taniguchi; Miyuki Nishiguchi; Yasuhiro Fukumori; Tsukasa Seya; Misako Matsumoto
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 6.  Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis.

Authors:  S Sriskandan; J Cohen
Journal:  Infect Dis Clin North Am       Date:  1999-06       Impact factor: 5.982

7.  Toll-like receptor 6-independent signaling by diacylated lipopeptides.

Authors:  Ute Buwitt-Beckmann; Holger Heine; Karl-Heinz Wiesmüller; Günther Jung; Roland Brock; Shizuo Akira; Artur J Ulmer
Journal:  Eur J Immunol       Date:  2005-01       Impact factor: 5.532

8.  The sepsis syndrome in a Dutch university hospital. Clinical observations.

Authors:  H Kieft; A I Hoepelman; W Zhou; M Rozenberg-Arska; A Struyvenberg; J Verhoef
Journal:  Arch Intern Med       Date:  1993-10-11

9.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure.

Authors:  K M Kengatharan; S De Kimpe; C Robson; S J Foster; C Thiemermann
Journal:  J Exp Med       Date:  1998-07-20       Impact factor: 14.307

View more
  10 in total

Review 1.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

2.  Bacterial Lipoproteins Constitute the TLR2-Stimulating Activity of Serum Amyloid A.

Authors:  Edward J Burgess; Laura R Hoyt; Matthew J Randall; Madeleine M Mank; Joseph J Bivona; Philip L Eisenhauer; Jason W Botten; Bryan A Ballif; Ying-Wai Lam; Matthew J Wargo; Jonathan E Boyson; Jennifer L Ather; Matthew E Poynter
Journal:  J Immunol       Date:  2018-08-29       Impact factor: 5.422

3.  Characterization of the fibrinogen binding domain of bacteriophage lysin from Streptococcus mitis.

Authors:  Ho Seong Seo; Paul M Sullam
Journal:  Infect Immun       Date:  2011-06-20       Impact factor: 3.441

4.  Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid to recruit neutrophils in the mammary gland and to stimulate mammary epithelial cells.

Authors:  Salim Bougarn; Patricia Cunha; Abdallah Harmache; Angélina Fromageau; Florence B Gilbert; Pascal Rainard
Journal:  Clin Vaccine Immunol       Date:  2010-09-08

5.  The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.

Authors:  Jun Ho Jeon; Hae-Ri Lee; Min-Hee Cho; Ok-Kyu Park; Jungchan Park; Gi-eun Rhie
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

6.  Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid.

Authors:  Lisa Maudsdotter; Hans Jonsson; Stefan Roos; Ann-Beth Jonsson
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

7.  Lipoteichoic acid in Streptomyces hygroscopicus: structural model and immunomodulatory activities.

Authors:  Marlène Cot; Aurélie Ray; Martine Gilleron; Alain Vercellone; Gérald Larrouy-Maumus; Elise Armau; Sophie Gauthier; Gérard Tiraby; Germain Puzo; Jérôme Nigou
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

8.  The Role of TLR2 in Infection and Immunity.

Authors:  Laura Oliveira-Nascimento; Paola Massari; Lee M Wetzler
Journal:  Front Immunol       Date:  2012-04-18       Impact factor: 7.561

9.  Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2.

Authors:  Hyun Young Kim; Min-Kyoung Song; Yong Song Gho; Hong-Hee Kim; Bong-Kyu Choi
Journal:  J Extracell Vesicles       Date:  2021-10

10.  Streptococcus uberis strains isolated from the bovine mammary gland evade immune recognition by mammary epithelial cells, but not of macrophages.

Authors:  Juliane Günther; Anna Czabanska; Isabel Bauer; James A Leigh; Otto Holst; Hans-Martin Seyfert
Journal:  Vet Res       Date:  2016-01-07       Impact factor: 3.683

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.